Chris Takimoto

Chris Takimoto

Chief Tech/Sci/R&D Officer chez IGM BIOSCIENCES, INC.

Fortune : 1 M $ au 29/02/2024

65 ans
Consumer Services
Health Technology

Profil

Chris H.
Takimoto
is Chief Medical Officer at IGM Biosciences, Inc. In the past Dr. Takimoto held the position of Senior Vice President-Oncology at Gilead Sciences, Inc. and Chief Medical Officer for Forty Seven, Inc. (a subsidiary of Gilead Sciences, Inc.), Senior Director-Translational Medicine at Ortho Biotech Oncology Research & Development, VP-Experimental Medicine Early Development at Janssen Global Services LLC and Associate Professor at the University of Texas Health Science Center At San Antonio.
Chris H.
Takimoto
received an undergraduate degree from Stanford University, a doctorate from Yale University and a doctorate from Yale School of Medicine.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
14/03/2024 94 388 ( 0,29% ) 1 M $ 29/02/2024

Postes actifs de Chris Takimoto

SociétésPosteDébut
IGM BIOSCIENCES, INC. Chief Tech/Sci/R&D Officer 29/07/2021
Tous les postes actifs de Chris Takimoto

Anciens postes connus de Chris Takimoto

SociétésPosteFin
GILEAD SCIENCES, INC. Corporate Officer/Principal 01/07/2021
FORTY SEVEN, INC. Chief Tech/Sci/R&D Officer 01/04/2020
Corporate Officer/Principal 01/01/2016
Ortho Biotech Oncology Research & Development Corporate Officer/Principal 01/01/2010
University of Texas Health Science Center At San Antonio Corporate Officer/Principal -
Voir l'expérience en détail de Chris Takimoto

Formation de Chris Takimoto

Stanford University Undergraduate Degree
Yale University Doctorate Degree
Yale School of Medicine Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Chris Takimoto

Relations

55

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées1
GILEAD SCIENCES, INC.

Health Technology

Entreprise privées4

Health Technology

IGM Biosciences, Inc.

Ortho Biotech Oncology Research & Development

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Chris Takimoto